Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Xin Meng,1 Ziling Zeng,2 Yunda Wang,3 Shuai Guo,1 Chunjuan Wang,2 Baojie Wang,1 Shougang Guo1,2 1Department of Neurology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Neurology, Shandong Provincial Hospita...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Meng X, Zeng Z, Wang Y, Guo S, Wang C, Wang B
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Dove Medical Press 2022-05-01
Seri Bilgileri:Neuropsychiatric Disease and Treatment
Konular:
myasthenia gravis
rituximab
low-dose
muscle-specific kinase
Online Erişim:https://www.dovepress.com/efficacy-and-safety-of-low-dose-rituximab-in-anti-musk-myasthenia-grav-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-low-dose-rituximab-in-anti-musk-myasthenia-grav-peer-reviewed-fulltext-article-NDT

Benzer Materyaller